The potential risks of drug interactions remain urgent and significant, underscoring the importance of thorough medication management and nursepharmacist collaboration
GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown
t hiu qu ti u, chng thng c kt hp vi chng nng, ng v ch n giu cht chng oxy ha
Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation
Incretins and cardiovascular disease: to the heart of type 2 diabetes
Many research frameworks start between 100 and 250 mcg daily for the first 3 days